Plagiarism Today

MARCH 7, 2022

Between him coming out as gay, being identified as a gifted student, bringing a knife to school and, in a recent episode, becoming dependent upon drugs to do well in school, the 14-year-old character has received a great deal of focus and attention through the show’s four seasons. Darlene finds the money. This sparks a debate between the two.

Plagiarism 159

Plagiarism Contracts Law 159

43(B)log

NOVEMBER 13, 2023

of survey respondents selected “Pharmacy operates in full compliance with Section 503A regarding compounded drugs” under the FDCA as an important factor in selecting a compounding pharmacy, in a separate question, 57.4% Defendants’ proposed expert on the same topic got in too. Although 54.1%

False Advertising 71

False Advertising Advertising Advertising Government 71

43(B)log

AUGUST 9, 2021

5, 2021) Scilex sells an FDA-approved, prescription-strength topical analgesic self-adhesive patch, ZTlido (lidocaine), which is allegedly often prescribed off-label, including for general neuropathic pain (e.g., Scilex didn’t explain why such an ad would lead consumers to believe that the product is FDA-approved or prescription-only.

False Advertising 59

False Advertising Advertising Advertising Marketing 59

IPilogue

AUGUST 5, 2021

Psilocybin, an active compound in what is commonly known as “magic mushrooms”, is currently listed under Schedule III of Canada’s Controlled Drugs and Substances Act. Under this Act , it is illegal to possess, obtain, or produce psilocybin without a prescription or licence. In 2020, the sales of cannabis products hit $2.6

Patent 59

Patent Invention Journalism Ownership 59

LexBlog IP

JULY 16, 2023

As with the agency’s earlier studies on these same topics (2021), the refreshed data again demonstrates that Orange Book patents are very rarely subject to AIA trial proceedings, and that abusive, serial petition filings have been effectively outlawed for years now.

Patent 52

Patent Litigation Intellectual Property 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Biosimilar Drug. In 2021, regulatory agencies focused on three interrelated issues: (1) decreasing anti-competitive behavior in the biosimilars space, (2) lowering biologic drug prices, and (3) providing further guidance to clarify the regulatory pathway for biosimilars. Tackling Biologic Drug Pricing. Reference Product.

Litigation 52

Litigation Settlement Patent Marketing 52

Patently-O

JULY 9, 2021

Prescription Drugs : Drug prices are higher in the US than in any other country — even for the identical product. More to come on this topic. The FTC is being asked to ban occupational licensing requirements that impede economic mobility. This is largely a construct of Federal Law.

Licensing 101

Licensing Intellectual Property Privacy IP 101